Pregabalin misuse: the next wave of prescription medication problems

Bridin Murnion and Katherine M Conigrave
Med J Aust 2019; 210 (2): . || doi: 10.5694/mja2.12056
Published online: 4 February 2019

Overseas experience need not portend the future of prescription drug misuse in Australia

Dispensing data indicate that pregabalin prescribing in Australia is rising rapidly, and the numbers of self‐poisonings and deaths are also increasing.1 This mirrors the European and North American experience of escalating misuse and harms.2,3 Although Australian guidelines recommend it only as second line treatment for neuropathic pain,4 pregabalin is now the seventh most expensive drug in terms of Pharmaceutical Benefits Scheme (PBS) expenditure.5

  • Bridin Murnion1,2
  • Katherine M Conigrave2,3

  • 1 Drug and Alcohol Services, Wyong Hospital, Wyong, NSW
  • 2 University of Sydney, Sydney, NSW
  • 3 Drug Health Services, Royal Prince Alfred Hospital, Sydney, NSW

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.